Obesity Treatment Market Size, Trends, Analysis, and Outlook By Drugs (Combination Drugs, Appetite Suppressants, Malabsorption & Satiety Drugs), By Surgery & Devices (Adjustable Gastric Banding, Roux-en-Y Gastric Bypass, Sleeve Gastrectomy, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures), by Region, Country, Segment, and Companies, 2024-2030
The global Obesity Treatment market size is poised to register 13.49% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Obesity Treatment market across By Drugs (Combination Drugs, Appetite Suppressants, Malabsorption & Satiety Drugs), By Surgery & Devices (Adjustable Gastric Banding, Roux-en-Y Gastric Bypass, Sleeve Gastrectomy, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures).
The Obesity Treatment Market is witnessing growth driven by the rising prevalence of obesity and metabolic disorders worldwide, and the demand for effective medical interventions and lifestyle modifications to address obesity-related health complications. Obesity is a complex multifactorial condition characterized by excess body fat accumulation, which increases the risk of chronic diseases such as type 2 diabetes, cardiovascular disease, and certain cancers. Key trends shaping its future include the development of novel pharmacotherapies and biologic agents targeting appetite regulation, energy metabolism, and fat absorption pathways for weight management and obesity-related comorbidity prevention, the integration of digital health platforms and mobile apps for behavior modification, nutritional counseling, and exercise coaching, and the customization of obesity treatment programs with bariatric surgery and minimally invasive procedures for individuals with severe obesity or metabolic syndrome. Additionally, factors such as the increasing awareness of obesity as a public health crisis, the expansion of reimbursement coverage for obesity treatments and preventive services, and the regulatory approvals of anti-obesity drugs and medical devices are expected to drive market growth in 2024 and beyond.
Obesity Treatment Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Obesity Treatment market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Obesity Treatment survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Obesity Treatment industry.
Key market trends defining the global Obesity Treatment demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Obesity Treatment Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Obesity Treatment industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Obesity Treatment companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Obesity Treatment industry
Leading Obesity Treatment companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Obesity Treatment companies.
Obesity Treatment Market Study- Strategic Analysis Review
The Obesity Treatment market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Obesity Treatment Market Size Outlook- Historic and Forecast Revenue in Three Cases
The Obesity Treatment industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Obesity Treatment Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Obesity Treatment Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Obesity Treatment market segments. Similarly, Strong end-user demand is encouraging Canadian Obesity Treatment companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Obesity Treatment market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Obesity Treatment Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Obesity Treatment industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Obesity Treatment market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Obesity Treatment Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Obesity Treatment in Asia Pacific. In particular, China, India, and South East Asian Obesity Treatment markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Obesity Treatment Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Obesity Treatment Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Obesity Treatment market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Obesity Treatment.
Obesity Treatment Market Company Profiles
The global Obesity Treatment market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Allergan Plc, Arena Pharmaceuticals Inc, Cousin Biotech, EnteroMedics Inc, Ethicon, F. Hoffmann-La Roche Ltd, Medtronic, Novo Nordisk A/S, USGI Medical Inc, VIVUS Inc
Recent Obesity Treatment Market Developments
The global Obesity Treatment market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Obesity Treatment Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
Market Segmentation:
By Drugs
Combination Drugs
Appetite Suppressants
Malabsorption & Satiety Drugs
By Surgery & Devices
Adjustable Gastric Banding
Roux-en-Y Gastric Bypass
Sleeve Gastrectomy
Biliopancreatic Diversion With Duodenal Switch
Endoscopic Procedures
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Companies
Allergan Plc
Arena Pharmaceuticals Inc
Cousin Biotech
EnteroMedics Inc
Ethicon
F. Hoffmann-La Roche Ltd
Medtronic
Novo Nordisk A/S
USGI Medical Inc
VIVUS Inc
Formats Available: Excel, PDF, and PPT